Pomalidomide is a crucial medication used to treat multiple myeloma, a type of blood cancer. As a derivative of thalidomide, it works by boosting the immune system and slowing cancer cell growth. The demand for high-quality Pomalidomide is growing, making reliable manufacturers essential for global healthcare.
Leading Pomalidomide manufacturers pharmaceutical companies specialize in producing Pomalidomide under strict quality controls. Major manufacturers include Bristol-Myers Squibb (Celgene), Natco Pharma, Hetero Labs, Dr. Reddy’s Laboratories, and Cipla, among others. These companies ensure compliance with international standards such as GMP (Good Manufacturing Practices) and FDA regulations to provide safe and effective treatment.